---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-049905"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:49:32.236831+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# QHSLab and SDSU receive NSF invitation to submit STTR application for AIR-GUIDDE technology

## Summary
- NSF invites QHSLab and South Dakota State University to submit full Phase I STTR application for AIR-GUIDDE drug delivery platform.
- Potential NSF funding: Phase I grants up to $305,000; Phase II up to $1.25 million.
- AIR-GUIDDE uses CFD modeling to accelerate development and target the $2.6B respiratory drug market.
- Project synergizes with QHSLab's existing digital medicine platforms and is non-dilutive to core business.
- CEO Troy Grogan says initiative validates company's innovation strategy and is fully aligned with growth plan.

## SEC filing metadata
- accession: 0001493152-24-049905
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224049905/0001493152-24-049905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224049905/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-049905
- JSON: https://secwatch.observer/filing/0001493152-24-049905.json
- Plain text: https://secwatch.observer/filing/0001493152-24-049905.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.